The chemistry paper behind SQ3370. It describes the injected biopolymer and four capped chemotherapy drugs, and explains why the doxorubicin one, SQP33, was taken forward.
From the University at Albany and Shasqi, this paper sets out the platform: a tetrazine-modified sodium hyaluronate biopolymer injected at a tumour, then systemic doses of a trans-cyclooctene (TCO)-modified cytotoxic prodrug of attenuated activity. The prodrug is captured by the biopolymer through an inverse electron-demand Diels-Alder reaction between tetrazine and TCO and then converted to the active drug at the site, independent of biomarker expression, enzymatic activity, pH or oxygen level.
TCO-modified forms of doxorubicin, paclitaxel, etoposide and gemcitabine were made. On cytotoxicity, solubility, stability and activation in the laboratory, the doxorubicin prodrug SQP33 was the most promising. In mice, the maximum tolerated dose of SQP33 with locally injected biopolymer (SQL70) was 19.1 times that of conventional doxorubicin. In rats, one injection of SQL70 captured several SQP33 doses given cumulatively at 10.8 times the maximum tolerated dose of conventional doxorubicin, with greatly reduced systemic toxicity. The combination, named SQ3370, showed anti-tumour activity in a syngeneic mouse model.
It names the two components of SQ3370 and the reaction that joins them, and shows the design is modular: the same activator can switch on different capped drugs.
Shares SQ3370, Shasqi, Click-activated prodrugs (bioorthogonal drug activation in the body).
Shares SQ3370, Shasqi, Click-activated prodrugs (bioorthogonal drug activation in the body).
Shares Shasqi, Click-activated prodrugs (bioorthogonal drug activation in the body).
Shares SQ3370, Shasqi, Click-activated prodrugs (bioorthogonal drug activation in the body).
Shares Shasqi, Click-activated prodrugs (bioorthogonal drug activation in the body).
Shares SQ3370, Shasqi, Click-activated prodrugs (bioorthogonal drug activation in the body).
Shares SQ3370, Shasqi, Click-activated prodrugs (bioorthogonal drug activation in the body).
Shares SQ3370, Click-activated prodrugs (bioorthogonal drug activation in the body).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/